Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within the National Preferred Drugs initiative in Ireland

Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within... Ir J Med Sci (2017) 186:631–639 DOI 10.1007/s11845-016-1535-2 O R I G IN AL ARTI CL E Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within the National Preferred Drugs initiative in Ireland 1,2 1,2 2 2 • • • G. O’Connor D. O’Keeffe C. Darker B. O’Shea Received: 11 April 2016 / Accepted: 21 December 2016 / Published online: 30 December 2016 Royal Academy of Medicine in Ireland 2016 Abstract Keywords Drug substitution  Preferred drugs  Drug Introduction A ‘Preferred Drugs’ initiative was introduced costs  Proton pump inhibitors into Ireland in 2013. This identified a single recommended drug to be prescribed to patients requiring treatment from a particular class of drugs. Introduction Aims This study investigates how patients on established proton pump inhibitor (PPI) therapy experienced the ther- Controlling drug costs is an important way to control health apeutic switching of their medication to the ‘preferred expenditure costs. Ever since the FDA published ‘‘Ap- drug’, and the extent to which they regarded it as an proved Drug Products with Therapeutic Equivalence acceptable practice. Evaluations’’, most countries have some laws or regula- Methods The experiences of 61 patients on established tions to encourage the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Irish Journal of Medical Science (1971 -) Springer Journals

Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within the National Preferred Drugs initiative in Ireland

Loading next page...
 
/lp/springer_journal/patient-acceptability-and-experiences-of-therapeutic-switching-of-56WK5wF3e2
Publisher
Springer London
Copyright
Copyright © 2016 by Royal Academy of Medicine in Ireland
Subject
Medicine & Public Health; Internal Medicine; General Practice / Family Medicine
ISSN
0021-1265
eISSN
1863-4362
D.O.I.
10.1007/s11845-016-1535-2
Publisher site
See Article on Publisher Site

Abstract

Ir J Med Sci (2017) 186:631–639 DOI 10.1007/s11845-016-1535-2 O R I G IN AL ARTI CL E Patient acceptability and experiences of therapeutic switching of proton pump inhibitors within the National Preferred Drugs initiative in Ireland 1,2 1,2 2 2 • • • G. O’Connor D. O’Keeffe C. Darker B. O’Shea Received: 11 April 2016 / Accepted: 21 December 2016 / Published online: 30 December 2016 Royal Academy of Medicine in Ireland 2016 Abstract Keywords Drug substitution  Preferred drugs  Drug Introduction A ‘Preferred Drugs’ initiative was introduced costs  Proton pump inhibitors into Ireland in 2013. This identified a single recommended drug to be prescribed to patients requiring treatment from a particular class of drugs. Introduction Aims This study investigates how patients on established proton pump inhibitor (PPI) therapy experienced the ther- Controlling drug costs is an important way to control health apeutic switching of their medication to the ‘preferred expenditure costs. Ever since the FDA published ‘‘Ap- drug’, and the extent to which they regarded it as an proved Drug Products with Therapeutic Equivalence acceptable practice. Evaluations’’, most countries have some laws or regula- Methods The experiences of 61 patients on established tions to encourage the

Journal

Irish Journal of Medical Science (1971 -)Springer Journals

Published: Dec 30, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off